Chinese Traditional and Herbal Drugs
|
2025, 56(13): 4890-4901
Research progress on traditional Chinese medicine against breast cancer through histone acetylation modifications
Full
WU Houman1,2, SI Fuchun1,2
Affiliations
1 School of Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450046, China; 2 Henan International Joint Laboratory of Signal Transduction of Traditional Chinese Medicine Formula-Syndrome, Zhengzhou 450046, China
About Author:
河南省科技研发计划联合基金(优势学科培育类)重点项目 (222301420024); 河南省科技攻关项目 (242102310582); 河南省博士后科研项目 (202103092)
doi: 10.7501/j.issn.0253-2670.2025.13.031
Outline
Breast cancer has emerged as the most prevalent malignancy among women, with its incidence showing an annual upward trend in recent years. Histone acetylation, a crucial epigenetic modification, has been found to participate in the pathogenesis and progression of breast cancer through dynamic regulation of chromatin structure and gene transcription activity, primarily mediated by the expression imbalance between histone acetyltransferases (HATs) and histone deacetylases (HDACs) during pathological processes. Traditional Chinese medicine (TCM) demonstrates unique therapeutic advantages in breast cancer treatment through its characteristics of multiple components and multiple targets. Studies have revealed that various TCM monomers, TCMs, and compound formulations containing terpenoids, phenols, flavonoids, and polysaccharides can regulate HAT and HDAC expression levels, thereby reversing aberrant histone acetylation patterns. These mechanisms ultimately induce tumor cell apoptosis or pyroptosis while inhibiting proliferation, invasion, and metastasis of breast cancer cells. This review systematically summarizes current research progress regarding the mechanisms by which TCM active components, TCMs and compound formulations exert anti-breast cancer effects through histone acetylation regulation across multiple pathways. The findings aim to provide theoretical foundations for the research and development and application of breast cancer drugs.
breast cancer
/
histone acetylation
/
traditional Chinese medicine
/
histone acetyltransferase
/
histone deacetylase
吴厚熳, 司富春.
中药基于组蛋白乙酰化修饰抗乳腺癌的研究进展.
中草药,
2025
, 56
(13)
: 4890
-4901
.
DOI: 10.7501/j.issn.0253-2670.2025.13.031
WU Houman, SI Fuchun.
Research progress on traditional Chinese medicine against breast cancer through histone acetylation modifications[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(13)
: 4890
-4901
.
DOI: 10.7501/j.issn.0253-2670.2025.13.031
Year 2025 volume 56 Issue 13
55
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.13.031
- Receive Date:2025-02-21
- Online Date:2026-11-12